MeVis Medical Solutions AG (LON:0HI7)

Market Cap	36.03M -8.6%
Revenue (ttm)	13.52M -6.9%
Net Income	1.21M -67.8%
EPS	0.66 -67.8%
Shares Out	n/a
PE Ratio	29.80
Forward PE	n/a
Dividend	0.82 (4.13%)
Ex-Dividend Date	Mar 20, 2026

Volume	n/a
Open	23.20
Previous Close	n/a
Day's Range	23.20 - 23.20
52-Week Range	22.00 - 26.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 30, 2026

About LON:0HI7

MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It also offers X-ray based radiography procedures, including computed tomography, mammography/digital tomosynthesis, magnetic resonance imaging, and digital sono...

• Industry: Prepackaged Software
• Founded: 1997
• Employees: 127
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0HI7

Financial Performance

In fiscal year 2025, LON:0HI7's revenue was 16.06 million, a decrease of -5.36% compared to the previous year's 16.97 million. Earnings were 3.17 million, a decrease of -30.58%.

Financial numbers in EUR

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 26, 2026

Data Sources Report a data error